These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34025426)

  • 21. Review: Human stem cell-based 3D in vitro angiogenesis models for preclinical drug screening applications.
    Esparza A; Jimenez N; Borrego EA; Browne S; Natividad-Diaz SL
    Mol Biol Rep; 2024 Feb; 51(1):260. PubMed ID: 38302762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced pluripotent stem cell technology as diagnostic tool in patients with suspected ornithine transcarbamylase deficiency lacking genetic confirmation.
    Ramosaj A; Singhal P; Schaller A; Laemmle A
    Mol Genet Metab Rep; 2023 Dec; 37():101007. PubMed ID: 38053928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organ-on-a-chip meets artificial intelligence in drug evaluation.
    Deng S; Li C; Cao J; Cui Z; Du J; Fu Z; Yang H; Chen P
    Theranostics; 2023; 13(13):4526-4558. PubMed ID: 37649608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering considerations of iPSC-based personalized medicine.
    Park S; Gwon Y; Khan SA; Jang KJ; Kim J
    Biomater Res; 2023 Jul; 27(1):67. PubMed ID: 37420273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A quantitative meta-analysis comparing cell models in perfused organ on a chip with static cell cultures.
    Dufva M
    Sci Rep; 2023 May; 13(1):8233. PubMed ID: 37217582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery.
    Sunildutt N; Parihar P; Chethikkattuveli Salih AR; Lee SH; Choi KH
    Front Pharmacol; 2023; 14():1139229. PubMed ID: 37180709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3D multicellular systems in disease modelling: From organoids to organ-on-chip.
    Goldrick C; Guri I; Herrera-Oropeza G; O'Brien-Gore C; Roy E; Wojtynska M; Spagnoli FM
    Front Cell Dev Biol; 2023; 11():1083175. PubMed ID: 36819106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiplexed microfluidic platform for stem-cell derived pancreatic islet β cells.
    Goswami I; de Klerk E; Carnese P; Hebrok M; Healy KE
    Lab Chip; 2022 Nov; 22(22):4430-4442. PubMed ID: 36305868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vitro Models for Studying Chronic Drug-Induced Liver Injury.
    Donato MT; Gallego-Ferrer G; Tolosa L
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering approaches for cardiac organoid formation and their characterization.
    Joddar B; Natividad-Diaz SL; Padilla AE; Esparza AA; Ramirez SP; Chambers DR; Ibaroudene H
    Transl Res; 2022 Dec; 250():46-67. PubMed ID: 35995380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validating the Arrhythmogenic Potential of High-, Intermediate-, and Low-Risk Drugs in a Human-Induced Pluripotent Stem Cell-Derived Cardiac Microphysiological System.
    Charwat V; Charrez B; Siemons BA; Finsberg H; Jæger KH; Edwards AG; Huebsch N; Wall S; Miller E; Tveito A; Healy KE
    ACS Pharmacol Transl Sci; 2022 Aug; 5(8):652-667. PubMed ID: 35983280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond pharmaceuticals: Fit-for-purpose new approach methodologies for environmental cardiotoxicity testing.
    Daley MC; Mende U; Choi BR; McMullen PD; Coulombe KLK
    ALTEX; 2023; 40(1):103-116. PubMed ID: 35648122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human organs-on-chips for disease modelling, drug development and personalized medicine.
    Ingber DE
    Nat Rev Genet; 2022 Aug; 23(8):467-491. PubMed ID: 35338360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics.
    Shroff T; Aina K; Maass C; Cipriano M; Lambrecht J; Tacke F; Mosig A; Loskill P
    Open Biol; 2022 Mar; 12(3):210333. PubMed ID: 35232251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery.
    Tricot T; Verfaillie CM; Kumar M
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aquaporin 9 induction in human iPSC-derived hepatocytes facilitates modeling of ornithine transcarbamylase deficiency.
    Laemmle A; Poms M; Hsu B; Borsuk M; Rüfenacht V; Robinson J; Sadowski MC; Nuoffer JM; Häberle J; Willenbring H
    Hepatology; 2022 Sep; 76(3):646-659. PubMed ID: 34786702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting
    He X; Sun H; Jiang Q; Chai Y; Li X; Wang Z; Zhu B; You S; Li B; Hao J; Xin S
    Front Oncol; 2021; 11():735447. PubMed ID: 34381736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microphysiological systems in absorption, distribution, metabolism, and elimination sciences.
    Van Ness KP; Cesar F; Yeung CK; Himmelfarb J; Kelly EJ
    Clin Transl Sci; 2022 Jan; 15(1):9-42. PubMed ID: 34378335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latest impact of engineered human liver platforms on drug development.
    Monckton CP; Brown GE; Khetani SR
    APL Bioeng; 2021 Sep; 5(3):031506. PubMed ID: 34286173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver-Heart on chip models for drug safety.
    Ferrari E; Rasponi M
    APL Bioeng; 2021 Sep; 5(3):031505. PubMed ID: 34286172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.